Cardiovascular Diseases

News Cardiovascular Diseases

• Thermo Fisher Scientific and Immundiagnostik Collaborate To Develop Mass Spectrometry-Based Clinical and Research Tools

  Thermo Fisher Scientific, Inc. and Immundiagnostik AG announced a collaboration to develop novel mass spectrometry-based assays for qualitative and quantitative analysis of proteins and peptides. The goal is development of commercial assays to be widely applicable in research and routine clinical an more

• BASF celebrates anniversary of Minden site

  What do caffeine, theophylline and ephedrine have in common? All three active pharmaceutical ingredients are manufactured in the world's largest plants at BASF's Minden site. Numerous guests were invited to attend the on-site 75th anniversary celebration incorporating a tour of the production plants more

• Cadmium: New challenge for food safety?

  Cadmium is not wanted in food as it can damage health. In January 2009 the European Food Safety Authority (EFSA) established a new guidance value for the lifelong tolerable weekly intake of the heavy metal. The new value of 2.5 µg per kilogram body weight is far lower than the previous value of 7 µg more

Publications Cardiovascular Diseases

• Methyl nutrients, DNA methylation, and cardiovascular disease

  Diet plays an important role in the development and prevention of cardiovascular disease (CVD), but the molecular mechanisms are not fully understood. DNA methylation has been implicated as an underlying molecular mechanism that may account for the effect of dietary factors on the development and more

• Synthesis and in Vitro and in Vivo Characterization of Highly β1-Selective β-Adrenoceptor Partial Agonists

  β-Adrenoceptor antagonists boast a 50-year use for symptomatic control in numerous cardiovascular diseases. One might expect highly selective antagonists are available for the human β-adrenoceptor subtype involved in these diseases, yet few truly β1-selective molecules exist. To address this clinica more

• Measurement of apo(a) kinetics in human subjects using a microfluidic device with tandem mass spectrometry

  RATIONALE Apolipoprotein(a) [apo(a)] is the defining protein component of lipoprotein(a) [Lp(a)], an independent risk factor for cardiovascular disease. The regulation of Lp(a) levels in blood is poorly understood in part due to technical challenges in measuring Lp(a) kinetics. Improvements in t more

Market studies Cardiovascular Diseases

• Production situation and future development of niacin in China

  Niacin is also known as Vitamin B3, including nicotinamide and nicotinic acid. Both of them play the same physiological role. In China, the content of nicotinamide accounts for 90% in Vitamin B3. In the 1960s, China began to produce niacin, but the niacin output was not high due to the inadequate s more

Websites Cardiovascular Diseases